Table 5. Independent predictors of OS and DFS in human MPNST.
| Disease-free survival | χ2 | P | HR | 95.0% CI | Overall survival | χ2 | P | HR | 95.0% CI | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | Lower | Upper | ||||||||
| NF1(no/yes) | 11.34 | .001 | .141 | 0.0451 | 0.4409 | NF1 (no/yes) | 1.918 | .166 | .475 | 0.166 | 1.3615 |
| AJCC | 5.779 | .123 | Recurrence (yes/no) | 5.740 | .017 | 2.918 | 1.2151 | 7.0054 | |||
| AJCC (1/4) | 1.852 | .174 | .445 | 0.1384 | 1.4286 | Metastasis (yes/no) | 1.767 | .184 | 1.653 | 0.7879 | 3.4689 |
| AJCC (2/4) | 2.378 | .123 | .522 | 0.2285 | 1.1926 | FGFR1 (high/low ) | 5.402 | .020 | .357 | 0.1495 | 0.8508 |
| AJCC (3/4) | 4.546 | .033 | .250 | 0.0698 | 0.894 | ||||||
| FGFR4 (high/low) | 3.305 | .069 | 3.865 | 0.8997 | 16.6 | ||||||